Understanding how long people with transthyretin amyloid cardiomyopathy (ATTR-CM) live when they take tafamidis as part of their regular healthcare: a plain language summary
Authors
Martin Carlsson (ORCID: https://orcid.org/0000-0003-3106-0754)
Matthew J. Maurer (ORCID: https://orcid.org/0000-0002-1867-0526)
Pablo García‐Pavía (ORCID: https://orcid.org/0000-0002-5470-2257)
Arnt V. Kristen (ORCID: https://orcid.org/0000-0001-7657-3700)
Brian Drachman
Leslie Amass
Institutions
Pfizer (United States) (US)
Heidelberg University (DE)
Universidad Francisco de Vitoria (ES)
Spanish National Centre for Cardiovascular Research (ES)
Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
Hospital Universitario Puerta de Hierro Majadahonda (ES)
Understanding how long people with transthyretin amyloid cardiomyopathy (ATTR-CM) live when they take tafamidis as part of their regular healthcare: a plain language summary
Martin Carlsson, Matthew J. Maurer, Pablo García‐Pavía, Arnt V. Kristen et al.
Journal
Future Cardiology
Topics
Amyloidosis: Diagnosis, Treatment, Outcomes
article
Understanding how long people with transthyretin amyloid cardiomyopathy (ATTR-CM) live when they take tafamidis as part of their regular healthcare: a plain language summary
Martin Carlsson, Matthew J. Maurer, Pablo García‐Pavía, Arnt V. Kristen, Brian Drachman, Leslie Amass
article en
Abstract
No abstract available for this paper.
Publication Tag
Future CardiologyVol. 21(7)
Institutions
Pfizer (United States) (US), Heidelberg University (DE), Universidad Francisco de Vitoria (ES), Spanish National Centre for Cardiovascular Research (ES), Centro de Investigación en Red en Enfermedades Cardiovasculares (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), University of Pennsylvania Health System (US), Columbia University (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Understanding how long people with transthyretin amyloid cardiomyopathy (ATTR-CM) live when they take tafamidis as part of their regular healthcare: a plain language summary — Martin Carlsson, Matthew J. Maurer, et al. · Future Cardiology (2025) | TGRS Research Map | TGRS